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Summary box
 ► Compensation packages were developed for house-
holds randomised to the control arm of an interven-
tional trial in Guatemala, India, Peru and Rwanda, 
with the aim of reducing differential bias and incen-
tivising continued engagement.
 ► A two-step process involving development of guid-
ing principles followed by site-specific formative re-
search was undertaken.
 ► The resultant compensation packages differed 
across the four sites while adhering to the overall 
guiding principles.
 ► The adaptive, context-specific approach taken 
here could inform control compensation in future 
multi-country trials.
AbSTrACT
The Household Air Pollution Intervention Network (HAPIN) 
trial is a randomised controlled trial in Guatemala, India, 
Peru and Rwanda to assess the health impact of a clean 
cooking intervention in households using solid biomass for 
cooking. The HAPIN intervention—a liquefied petroleum 
gas (LPG) stove and 18-month supply of LPG—has 
significant value in these communities, irrespective of 
potential health benefits. For control households, it was 
necessary to develop a compensation strategy that would 
be comparable across four settings and would address 
concerns about differential loss to follow-up, fairness 
and potential effects on household economics. Each site 
developed slightly different, contextually appropriate 
compensation packages by combining a set of uniform 
principles with local community input. In Guatemala, 
control compensation consists of coupons equivalent 
to the LPG stove’s value that can be redeemed for the 
participant’s choice of household items, which could 
include an LPG stove. In Peru, control households receive 
several small items during the trial, plus the intervention 
stove and 1 month of fuel at the trial’s conclusion. 
Rwandan participants are given small items during the trial 
and a choice of a solar kit, LPG stove and four fuel refills, 
or cash equivalent at the end. India is the only setting 
in which control participants receive the intervention 
(LPG stove and 18 months of fuel) at the trial’s end while 
also being compensated for their time during the trial, in 
accordance with local ethics committee requirements. The 
approaches presented here could inform compensation 
strategy development in future multi-country trials.
InTroduCTIon
The Household Air Pollution Intervention 
Network trial (HAPIN) is a multi-country 
randomised controlled trial (RCT) of a clean 
cookstove and fuel intervention for pregnant 
women who cook with biomass fuels, such as 
wood and dung. The trial seeks to evaluate 
the effect of switching to clean fuel cooking 
during pregnancy and the infant’s first year of 
life on the primary outcomes of birth weight, 
linear growth and severe pneumonia in the 
child, as well as blood pressure in older adult 
women who reside with the pregnant women. 
In total, 3200 pregnant women are being 
enrolled, 800 each in Guatemala, India, Peru 
and Rwanda. Activities are led by country-spe-
cific Intervention Research Centres (IRCs). 
Households randomised to the intervention 
arm receive a liquefied petroleum gas (LPG) 
stove and a continuous supply of free LPG 
from early pregnancy through the child’s first 
birthday, approximately 18 months per partic-
ipant. The issue of appropriate compensation 
for households randomised to the control 
arm of HAPIN was the subject of extensive 
discussions and data gathering during the 
HAPIN formative research period, reported 
here.
Compensation packages for participation 
in research vary widely, including in low-in-
come and middle-income country settings.1 
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Much of the literature has concerned appropriate 
levels of financial compensation, reflecting the fact that 
cash is a typical form of compensation in the USA and 
Europe.2 Cash is often valued over in-kind goods because 
it provides maximal flexibility in how it is spent or saved. 
Discussions of goods-based and service-based compensa-
tion are more rare, despite the fact that these types of 
compensation are often provided in low-income and 
middle-income country settings.3–5
In randomised trials, control compensation frequently 
consists of deferred receipt of the intervention. HAPIN 
initially conceived of control compensation similarly, 
planning to provide control participants with a stove and 
18 months of LPG at the conclusion of trial participation. 
In early discussions, however, this approach was deemed 
inadequate for HAPIN for three primary reasons.
First, HAPIN investigators worried that asking 
control households to wait 18 months before receiving 
compensation might introduce differential bias into 
the trial. Participation in HAPIN requires a substantial 
time commitment despite the fact that ethical reviews 
concluded that the risks of participation in HAPIN were 
minimal. HAPIN investigators reasoned that the free, 
continuous supply of cooking fuel provided to interven-
tion households would serve as sufficient incentivisation 
for intervention participants to stay enrolled for the 18 
months of follow-up. Control participants would not 
receive this ongoing benefit, and for this reason might 
elect not to participate in the trial (potentially leading to 
selection bias), or might drop out of the trial at higher 
rates (resulting in differential losses to follow-up between 
arms).
Second, it is possible that the intervention could affect 
health outcomes by virtue of household economics rather 
than via a reduction in household air pollution. Interven-
tion households would not need to purchase or collect 
their own biomass fuel for the duration of the trial. Thus, 
the time and money previously spent on fuel could theo-
retically be spent in ways that could impact trial outcomes 
such as birth weight and child growth, for example, by 
diverting money that would have been spent on fuel to 
more nutritious food, or using time saved from collecting 
fuel to visit the health centre more frequently.
Lastly, HAPIN investigators were concerned about 
the perceptions of fairness at the community level 
that could emerge as a result of asking control house-
holds to participate in a trial over an 18-month period 
without receiving any ongoing compensation while 
intervention households in the same communities were 
receiving a valuable asset (LPG stove and free fuel) 
immediately. Participation in HAPIN involves visits to 
health clinics for ultrasound examinations and other 
assessments, and numerous home visits for environ-
mental sampling, child assessments of pneumonia and 
anthropometry, and collection of blood spot and urine 
for biomarkers. The HAPIN team worried that without 
ongoing compensation to control households there 
could be resentment between households that could 
create social disharmony and/or make the trial unwel-
come in the community.
As the team began formative research, it became clear 
that the original plan of deferred receipt of the inter-
vention could create logistical, scientific and potentially 
ethical problems. Designing appropriate incentives for 
control households therefore became of paramount 
importance. The compensation strategy needed to 
achieve the same goals in four diverse settings while also 
being contextually appropriate and satisfying local ethics 
authorities.
The work described here was approved by ethics review 
entities at Emory University, Johns Hopkins University, 
Universidad del Valle de Guatemala, the Guatemalan 
Ministry of Health, Sri Ramachandra Institute of Higher 
Education and Research, the Indian Council of Medical 
Research, the A.B. PRISMA, the London School of Trop-
ical Hygiene and Medicine, and the Rwandan National 
Ethics Committee. HAPIN is registered at  clinicaltrials. 
gov under identifier NCT02944682.
Development of control compensation packages 
occurred in two phases. First, a set of multi-country prin-
ciples was developed for the overall trial. Next, each IRC 
conducted formative research to build a package consis-
tent with those principles and acceptable to study partic-
ipants, trial investigators and ethics committees. HAPIN 
is currently tracking the effectiveness of these strategies 
at achieving the objectives mentioned earlier. This paper 
describes the compensation packages identified and the 
considerations informing their development. Outcomes 
will be analysed and presented after the trial concludes 
in 2021.
GuIdInG prInCIpleS
The principles underlying HAPIN’s control compensa-
tion strategy were developed in discussions with bioeth-
icists and ethics committees, and are shown in table 1. 
In short, they expressed three aims: (i) treat participants 
ethically, (ii) encourage controls to remain enrolled 
throughout the study and (iii) minimise the likelihood 
that the provision of LPG stoves and fuel to interven-
tion households could create economic differences that 
might affect the health outcomes of the trial.
SeTTInG-SpeCIfIC CompenSATIon plAnS
With this guidance, the IRCs designed formative research 
activities to further develop setting-specific compensa-
tion plans. Table 2 outlines each country’s activities. Each 
IRC determined the contextually appropriate combi-
nation of formative research activities for their setting, 
according to their prior experience conducting similar 
activities in the area. Participants were generally drawn 
from pools of individuals who would be similar to HAPIN 
participants (eg, pregnant women or mothers with chil-
dren under one from the community, their spouses 
and family members, and/or community members who 
had participated in a pilot study involving an LPG stove 
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Table 1 Multi-country guidance for development of compensation strategies
Aims Control households will receive compensation designed to meet 
three aims: (i) comply with applicable ethics requirements for 
treatment of controls, (ii) compensate control participants for the 
burden associated with the study, with a view to minimising losses 
to follow-up and (iii) offset the likely/potential economic advantage to 
intervention households accorded by the provision of free stoves and 
fuel
Trial-wide principles 1. Control compensation should not have the potential for impacting 
the outcomes of interest. For example, directly providing food would 
not be appropriate since it could impact HAPIN outcomes such as 
child growth and birth weight
2. Any strategy to be incorporated into the trial cannot intentionally 
incentivise practices or behaviours that might put the control group 
at risk of adverse health outcomes. For example, provision of wood 
fuel would not be appropriate. On the other hand, incentives can be 
conditioned on continued participation in the trial
3. The strategy should be created in consideration of the potential for 
other adverse effects of the compensation, such as disputes about 
who in the household receives and can use the incentive
  
4. The strategies must be approved by applicable ethics committees 
and the HAPIN Data and Safety Monitoring Board
HAPIN, Household Air Pollution Intervention Network.
who would have familiarity with this technology and the 
burden of participating in a research study). The IRCs 
were in contact with one another throughout the design 
and conduct of the formative research through weekly 
team meetings held via teleconference. The progress and 
results of these activities were also discussed during an 
in-person meeting in September 2017.
Lastly, each HAPIN IRC used the information gath-
ered from the formative research activities to propose 
compensation packages for HAPIN participants. These 
were subsequently presented to the HAPIN investiga-
tors, institutional ethics committees and the HAPIN Data 
Safety Monitoring Board for approval. In some cases, 
feedback from these groups was incorporated into the 
final packages, with major changes discussed below.
The final compensation packages for HAPIN house-
holds are described in table 3. The specifics of the 
compensation plans differ by IRC in terms of timing of 
delivery, the nature of the items provided and the total 
cost per household.
In Peru and Rwanda, for example, gift items will be 
provided to control participants at designated points 
throughout their participation in the trial. These items 
were mentioned during the formative research: sweaters 
and hats in the case of Peru and kitenge cloth in the case 
of Rwanda. At baseline, all Rwandan participants will 
receive a table (which serves as an LPG stove base for 
intervention households). At the conclusion of HAPIN 
participation, control households in Peru will receive an 
LPG stove and cooking package (stove, one cylinder of 
LPG and pressure cooker). Rwandan controls will be able 
to choose from several options at the end of the study: an 
LPG package, a solar kit, or a cash equivalent.
The Guatemala IRC decided on a different approach: 
control participants would be able to choose from a 
catalogue of items of varying value, with included items 
selected by working group members. Control house-
holds will receive a total of four coupons worth GTQ 500 
(US$67) each, which they can use to purchase items at 
the time of receipt or apply towards the purchase of a 
larger item at the study’s end. The wait would increase in 
proportion to an item’s value: higher-priced items (LPG 
stove, refrigerator, dining table and chairs, clothes ward-
robe) would require waiting until the end of the trial. 
A shorter wait would be required for smaller items (eg, 
clothes iron, set of dishes, blender).
In India, formative research suggested that cash 
compensation—equivalent to the amount spent on stoves 
and LPG fuel for an intervention household—might be 
appropriate for controls. India has previously used condi-
tional cash transfers successfully to motivate desired 
behaviours such as giving birth in health facilities.6 This 
cash-based compensation plan, however, was rejected 
by the Sri Ramachandra Institute of Higher Education 
and Research ethics board. The board stipulated that the 
India team must not provide monetary compensation to 
either study arm except to reimburse transportation costs 
and lost wages, and directed that at the end of the trial, 
the India IRC research team must provide controls with 
exactly the same package that intervention households 
receive. As this advice generally aligned with the multi-
country guidance, it was decided that control households 
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Table 2 Formative research activities at each Intervention Research Centre
Country Activity Participants Example of task
Guatemala Working groups Four working groups with 52 participants 
total: women and their spouses and/or other 
adult household members, all of whom 
had participated in a pilot of the LPG stove 
intervention
Asked to list household items a control 
household might like to have (within 
constraints); top responses voted on
India In-depth 
interviews
20 participants, with purposive mix of (1) 
participants in an LPG pilot, (2) participants 
considered for the pilot who did not meet 
inclusion criteria and (3) new participants with 
no previous study connexion
Semi-structured interview on 
perspectives about randomised 
controlled trial participation, feelings 
about selection as a control and possible 
compensation for control participants
Formal 
discussion
Six village health nurses in study area Same semi-structured interview as for 
in-depth interviews (see above)
Peru In-depth 
interviews
Seven pregnant women Asked about typical gifts received by 
new mothers, typical fuel collection/
purchasing practices and perceptions 
about LPG
Focus group One discussion with seven women (either 
pregnant or new mothers)
Discussed common household 
expenditures, valued items for women 
and new mothers, and methods for 
showing appreciation to those who 
provide help
Rwanda Survey in 
antenatal clinics
60 pregnant women Questions covered acceptability of 
different compensation strategies, 
including types of compensation, 
frequency of compensation and waiting 
periods for larger items
Focus group 
discussions
Two discussions, each with eight former 
participants in LPG pilot and their husbands
Discussion of options to maintain control 
participants’ engagement and to ensure 
participants maintain trust that the study 
team will deliver larger items at the end of 
the trial
LPG, liquefied petroleum gas.
in India would be given an LPG stove identical to the one 
received by intervention households, plus credit towards 
an equal amount of LPG. Institutional review boards and 
ethics boards in the other three IRCs allowed plans as 
proposed.
leSSonS leArned
Initially, HAPIN planned to compensate control partic-
ipants at trial’s end with a package identical to that 
received by intervention households: an LPG stove 
plus 18 months of fuel. It soon became clear that this 
approach presented a variety of problems, from poten-
tial to introduce differential bias into the study to 
concerns about the fairness of asking control households 
to undergo multiple study procedures over an 18-month 
period without ongoing compensation. After integrating 
input from local staff, formative research, study commu-
nity members, ethics committees, and experts, the plan 
that emerged instead consisted of a set of compensa-
tion packages based on uniform guiding principles and 
adapted to the different contexts of the four IRCs. These 
were implemented in April 2018 as enrolment began. 
As the trial progresses, HAPIN investigators are closely 
monitoring control compensation packages to ensure 
they are meeting the original goals (ie, to maximise 
engagement and minimise differential attrition in the 
control arm).
Different models for compensating research partici-
pants have been suggested in the literature.7–9 According 
to the free market model, participants would be paid 
competitive rates based on the principles of supply 
and demand (eg, adjusted to meet recruitment goals). 
Under wage-payment, payment would align with local 
rates for unskilled labour and would be provided based 
on the time participants devote to research activities. 
The reimbursement model suggests reimbursement of 
actual expenses (eg, transport and lost wages). Appreci-
ation models suggest that research participation is less 
a form of labour than a type of altruistic engagement, 
and that compensation therefore should not be based 
on market rates but rather seen as an expression of grat-
itude for participating. These models are not mutually 
exclusive, and scholars have suggested that ‘the best way 
of establishing an appropriate level of payment may be 
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to use some combination of these different approaches, 
depending on the type of research being conducted’.7
These models were never explicitly discussed during 
development of the HAPIN control compensation strat-
egies. Examination after the fact, however, suggests that 
the strategies combined elements of several models. The 
predominant model combined ‘free market’ principles 
(because compensation levels were designed to be high 
enough to encourage recruitment and retention) with 
‘appreciation’ (because in general the items provided—
particularly the baby and household items—were explic-
itly framed as ‘gifts’ and thus distanced from the language 
of work and labour). India was the only IRC to employ 
the ‘reimbursement’ and ‘wage-payment’ models along-
side the others, in its provision of travel and lost-wage 
stipends to participants.
Limited research exists on preferred compensation 
mechanisms in low-income and middle-income settings. 
Participants in a Kenya study preferred cash payments, 
due to their flexibility.5 However, these participants 
distinguished between reimbursements for direct costs 
(eg, transportation and lost wages)—which were highly 
preferred in cash—and tokens of appreciation, for which 
goods were preferred. An important consideration here 
may be that biomass-using households are on the lower 
end of the socioeconomic spectrum. One common argu-
ment in the literature suggests that financial remuner-
ation is more attractive to economically disadvantaged 
populations and might lead to distorted perceptions of 
risk.10 Others, however, argue that removing cash from 
the menu of options for the socioeconomically disad-
vantaged is a form of paternalism that limits the options 
of research participants rather than protecting them8 
and could actually disproportionately exclude poorer 
participants.2
No other site besides India included cash reimburse-
ments (for travel or wages) as compensation. Cash as a 
form of appreciative compensation, meanwhile, appears 
only in Rwanda, where a cash payment is among the 
options that may be chosen by control households at the 
conclusion of the trial. The other IRCs all decided on 
goods-based compensation, though some (Guatemala 
and Rwanda) incorporated elements of flexibility and 
choice into their packages.
Though not explicitly outlined in the multi-country 
guidance (table 1), equity between control and interven-
tion arms came up repeatedly in community and ethics 
board discussions. The clearest example was in India, 
where an ethics board mandated that control households 
receive a compensation package identical to the inter-
vention one. This makes India the only setting in which 
control and intervention packages are monetarily equal, 
each valued at US$383 (see online Supplementary tables 1 
and 3). In the other settings, the market value of the inter-
vention package remained greater than of the control 
package, sometimes significantly so. In Guatemala’s case, 
the intervention cost is US$1414 per household versus 
US$268 in compensation for each control household. 
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These differences reflect the cost of achieving the aims of 
the intervention in each locale. Each IRC designed their 
intervention according to a primary objective: to provide 
an LPG stove, fuel and any needed additional supplies 
that would enable households to complete all their 
cooking tasks exclusively and safely with this stove and 
fuel. For example, in Guatemala, a griddle is needed to 
cook tortillas, a staple food. The Guatemalan IRC chose 
a three-burner stove incorporating a griddle as their 
intervention stove, which raised costs here. Although 
we believe that equity between intervention and control 
households in HAPIN is best calibrated to the burden on 
study participation rather than the financial expense of 
delivering the intervention, these details highlight the 
complexity of deciding what is ‘fair’ when interventions 
are seen as having actual market value.
In Rwanda, a key challenge uncovered during forma-
tive research was that few rural households had prior 
experience with LPG. Providing an LPG stove at trial’s 
end, therefore, was not viewed as favourably in Rwanda as 
in India, where the nation-wide Pradhan Mantri Ujjwala 
Yojana campaign has increased LPG awareness and acces-
sibility, even in rural areas.11 LPG access has also been 
increasing rapidly in Peru, partly due to a nation-wide 
government subsidy programme that provides discounted 
LPG to poor, rural families.12 In Rwanda, it was important 
to offer other compensation items valued in this commu-
nity: in this case, a choice between an LPG package, a 
solar kit and/or a cash deposit equivalent in value to 
the two other options. In Guatemala, awareness of LPG 
was higher but formative research participants worried 
they would likely not be able to afford to purchase LPG 
regularly post-trial. The Guatemala IRC decided to allow 
control group participants to choose their compensation, 
given that an LPG stove provided at the end might have 
little value to households who could not afford enough 
fuel to use it regularly.
The third criterion for control compensation was 
that strategies minimise the potential economic advan-
tage created by the LPG stoves and fuel via reductions 
in purchased fuel costs and in time spent cooking and 
collecting fuel. In the end, however, HAPIN’s team 
concluded that the direction and strength of any poten-
tial economic effect associated with the provision of free 
LPG fuel to HAPIN households is not something that 
can be assumed a priori, but rather is a research question 
of its own to be investigated over the course of the trial. 
For example, many HAPIN participants typically collect 
biomass fuel themselves, drawing on abundant and acces-
sible supplies of wood and/or animal dung. Receiving 
free LPG where biomass fuel is already free may confer 
no economic advantage that could improve health status. 
It is, likewise, not yet clear how much time savings will 
accrue from avoided fuel collection, nor how participants 
might spend any such extra time. As a result, plans are 
underway to track and evaluate the economic impact 
of the intervention during the HAPIN trial via dietary 
surveys, questionnaires and time use studies. While 
not available until the trial concludes, data on these 
outcomes will contribute to the scant extant literature on 
the effects of in-kind transfers on economic and health 
outcomes in low-income and middle-income countries 
(eg, Gentilini,13 Cunham14 and McIntosh15).
ConCluSIonS
This paper illustrates how formative research, guided by 
common principles, can be used to develop cross-cut-
ting but locally appropriate strategies for compensating 
control group participants in a multi-country RCT. 
The diversity of compensation packages developed for 
HAPIN’s four countries suggests that one-size-fits-all 
approaches may not achieve their intended goals in multi-
country trials. Agreeing on general principles as central 
guidance, however, can usefully inform local implemen-
tation of contextually appropriate control compensation 
packages in low- and middle-income settings.
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